Peter Zdziarski/LinkedIn
Apr 13, 2026, 17:41
Peter Zdziarski: Glanzmann’s Research Foundation Listed as GT Patient Organization on NORD
Peter Zdziarski, Founder and Marketing Director of Glanzmann Thrombasthenia Advocacy Network, shared a post on LinkedIn:
“Proud to share that the Glanzmann’s Research Foundation, Inc. is now listed as a patient organization for GT on the National Organization for Rare Disorders website.
This is a meaningful step in helping more individuals and families affected by Glanzmann Thrombasthenia find trusted information and a supportive community of actual patients that much sooner.
Grateful to NORD for the work they do to elevate rare disease organizations and connect people to the resources they need.”
More posts featuring Peter Zdziarski on Hemostasis Today.
-
May 31, 2026, 13:16Caroline Kisia: Project ECHO Transforms Healthcare Around The World
-
May 31, 2026, 13:11Wolfgang Miesbach: From CD20 to CD38 – A New Dimension in ITTP Therapy
-
May 31, 2026, 13:05Ellia Tootoonchian: Advancing Equitable Care Through Global Collaboration at WFH 2026
-
May 31, 2026, 12:55Rishiraj Sinha: Transfusion Evidence Library Round-Up – International Thalassaemia Day 2026
-
May 31, 2026, 12:40Tareq Abadl: Key Differences Between Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura
-
May 31, 2026, 12:37Jeyaraj Pandian: World Stroke Organization Advances Stroke Education and Care in Central Asia
-
May 31, 2026, 12:31Stephen James Ryan: We Validated the Norwegian Version of the Vision Impairment Screening Assessment in Stroke
-
May 31, 2026, 12:01Sheila Cristina Ouriques Martins: We Provide Practical, Real-World Examples on How to Implement Stroke Prevention Strategies
-
May 31, 2026, 11:51Seema Dawood: Principles of Blood Smear Examination and Interpretation